Advanced Glycation End Products, Oxidation Products, and Incident Cardiovascular Events in Patients With Type 2 Diabetes

OBJECTIVE: The goal of this study was to determine whether plasma levels of advanced glycation end products (AGE) and oxidation products (OP) predict the incidence of cardiovascular disease (CVD) in type 2 diabetes. RESEARCH DESIGN AND METHODS: Five specific AGE (methylglyoxal hydroimidazolone, carb...

Descripción completa

Detalles Bibliográficos
Autores principales: Koska, Juraj, Saremi, Aramesh, Howell, Scott, Bahn, Gideon, De Courten, Barbora, Ginsberg, Henry, Beisswenger, Paul J., Reaven, Peter D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2018
Materias:
Cardiovascular and Metabolic Risk
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5829965/
https://www.ncbi.nlm.nih.gov/pubmed/29208654
http://dx.doi.org/10.2337/dc17-1740

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5829965/
https://www.ncbi.nlm.nih.gov/pubmed/29208654
http://dx.doi.org/10.2337/dc17-1740

Ejemplares similares